Omission of Radiotherapy in Women >60 Years Old After Breast Conserving Surgery for Breast Cancer is Non-Inferior in Terms of Local Recurrence: A Retrospective Cohort Study

Overview

Journal Eur J Breast Health

Publisher Galenos Publishing House

Date 2024 Jan 8

PMID 38187101

Authors

Anna Sachoulidou

Fani Apostolidou

Charalambos Fronis

Despoina Misailidou

Aichan Bozoglou

Themis Anastasia Tataridou

Aristomenis Ampatzoglou

Ioannis Galanis

Affiliations

Soon will be listed here.

Abstract

Objective: Local recurrence rate may show no significant differences between women aged 60 and older who receive breast-conserving surgery followed by radiotherapy and those in the same age group who undergo breast-conserving surgery without subsequent radiotherapy.

Materials And Methods: Retrospective cohort study from a single practice with median follow-up time 44 months (interquartile range: 16, 82), comparing women older than 60 years old at diagnosis of breast cancer, treated with breast conserving surgery and either receiving or not receiving radiation therapy postoperatively. The primary endpoint was local recurrence difference between the two groups.

Results: Local recurrence did not differ significantly between the two groups in terms of radiotherapy or not [odds ratio (OR) 0.96, 95% confidence interval (CI) 0.89-1.02, Fisher's exact test = 0.388], nor between two age groups with cut-off at 65 years of age (OR: 0.99, 95% CI 0.92-1.07, Fisher's Exact test = 0.6). Local recurrence also did not differ when subgroups of age (60-65 years and >66 years) were considered. All patients received 5 years of hormonal therapy.

Conclusion: Omission of radiotherapy in selected patients is not inferior to radiotherapy after breast conserving surgery in terms of preventing local recurrence.

References

Kunkler I, Williams L, Jack W, Cameron D, Dixon J . Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N Engl J Med. 2023; 388(7):585-594. DOI: 10.1056/NEJMoa2207586. View

Zhong Y, Xu Y, Zhou Y, Mao F, Lin Y, Guan J . Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation. Sci Rep. 2020; 10(1):19481. PMC: 7655830. DOI: 10.1038/s41598-020-76663-5. View

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

Lai X, Han W, Zhang H, Hou J, Wang G, Luo X . Prognostic role of radiotherapy in low-risk elderly breast cancer patients after breast-conserving surgery: a cohort study. Gland Surg. 2022; 11(5):847-859. PMC: 9177274. DOI: 10.21037/gs-22-235. View

Savard M, Clemons M, Hutton B, Jemaan Alzahrani M, Caudrelier J, Vandermeer L . De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis. Cancer Treat Rev. 2021; 99:102254. DOI: 10.1016/j.ctrv.2021.102254. View

Kaidar-Person O, Giasafaki P, Boersma L, De Brouwer P, Weltens C, Kirkove C . Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/10925. Radiother Oncol. 2023; 185:109698. DOI: 10.1016/j.radonc.2023.109698. View

Tinterri C, Gatzemeier W, Costa A, Gentilini M, Zanini V, Regolo L . Breast-conservative surgery with and without radiotherapy in patients aged 55-75 years with early-stage breast cancer: a prospective, randomized, multicenter trial analysis after 108 months of median follow-up. Ann Surg Oncol. 2013; 21(2):408-15. DOI: 10.1245/s10434-013-3233-x. View

Cuschieri S . The STROBE guidelines. Saudi J Anaesth. 2019; 13(Suppl 1):S31-S34. PMC: 6398292. DOI: 10.4103/sja.SJA_543_18. View

Wickberg A, Liljegren G, Killander F, Lindman H, Bjohle J, Carlberg M . Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. Eur J Surg Oncol. 2018; 44(7):951-956. DOI: 10.1016/j.ejso.2018.04.002. View

10.

Stueber T, Diessner J, Bartmann C, Leinert E, Janni W, Herr D . Effect of adjuvant radiotherapy in elderly patients with breast cancer. PLoS One. 2020; 15(5):e0229518. PMC: 7239665. DOI: 10.1371/journal.pone.0229518. View

11.

Blamey R, Bates T, Chetty U, Duffy S, Ellis I, George D . Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer. 2013; 49(10):2294-302. DOI: 10.1016/j.ejca.2013.02.031. View

12.

Palumbo I, Borghesi S, Gregucci F, Falivene S, Fontana A, Aristei C . Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology). J Geriatr Oncol. 2021; 12(7):1130-1135. PMC: 8131185. DOI: 10.1016/j.jgo.2021.05.008. View

13.

Polgar C, Fodor J, Major T, Sulyok Z, Kasler M . Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol. 2013; 108(2):197-202. DOI: 10.1016/j.radonc.2013.05.008. View

14.

Yang S, Tan L, Zhou P, Lian C, Wu S, He Z . The addition of radiotherapy to breast-conserving surgery improves survival for elderly patients with early breast cancer. Front Oncol. 2022; 12:917054. PMC: 9727219. DOI: 10.3389/fonc.2022.917054. View

15.

Kunkler I, Williams L, Jack W, Cameron D, Dixon J . Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015; 16(3):266-73. DOI: 10.1016/S1470-2045(14)71221-5. View

16.

Ward M, Vicini F, Al-Hilli Z, Chadha M, Pierce L, Recht A . Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older. Breast Cancer Res Treat. 2020; 182(2):355-365. DOI: 10.1007/s10549-020-05706-2. View

17.

Killander F, Karlsson P, Anderson H, Mattsson J, Holmberg E, Lundstedt D . No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT. Eur J Cancer. 2016; 67:57-65. DOI: 10.1016/j.ejca.2016.08.001. View

18.

Wockel A, Wolters R, Wiegel T, Novopashenny I, Janni W, Kreienberg R . The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects. Ann Oncol. 2014; 25(3):628-632. PMC: 4433516. DOI: 10.1093/annonc/mdt584. View